CONNECT WITH US:
Feb 07, 2019 09:00 JST
Lubrizol LifeSciences to Showcase New Medical Device Applications Lab at MDM West 2019
CLEVELAND, Ohio, Feb 07, 2019 - (ACN Newswire) - The Lubrizol Corporation announces its LifeSciences business will feature a new medical device applications lab. LifeSciences has invested significantly to expand its global development and manufacturing facilities, and the latest investment is a new state-of-the-art medical device applications lab in Brecksville, Ohio. This lab features applications testing, small-scale compounding as well as injection molding for long-term implantables. The 1,800-square foot facility will also focus on accelerated R&D, from polymers to device scale up and testing in a short period of time.
The medical device applications lab is yet another substantial piece of LifeSciences' full-service capabilities. These capabilities and more will be on display at the MD&M West Exposition (Booth #2401), February 5-7. Lubrizol LifeSciences is a preferred medical device development partner, helping customers from concept to commercialization by offering polymer customization, drug-eluting device development and contract manufacturing services. At MD&M, LifeSciences will also highlight a strong presence in the interventional catheter, long-term implant and drug-eluting device markets. In addition, LifeSciences will unveil new dexamethasone-loaded polymers designed to minimize inflammation and help ensure the success of implantable medical devices.
"The new applications lab is another commitment to healthcare companies looking for a full-service development partner. We continue to invest in the right areas to provide valuable offerings where our customers are experiencing the most growth," states Uwe Winzen, general manager, Lubrizol LifeSciences. "When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process."
Offering more than 90 years of science and technology experience, Lubrizol is uniquely structured to partner with medical device manufacturers by providing proactive innovation, speed to market, and expertise for the most demanding projects. From materials to development and manufacturing, or anything in between - Lubrizol LifeSciences is equipped to support the needs of customers worldwide.
About Lubrizol LifeSciences
Lubrizol LifeSciences is a preferred Contract Development and Manufacturing Organization (CDMO) partner for complex pharmaceuticals and high-end medical devices providing differentiated polymers and excipients, along with state-of-the-art design, development and manufacturing services to the healthcare industry.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers' success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,700 employees worldwide. Revenues for 2017 were $6.3 billion. For more information, visit Lubrizol.com.
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire
Copyright ©2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Lubrizol Announces Global Collaboration with Corbion
June 18 2019 16:30 JST
Particle Sciences Expands Controlled Substance Capabilities with Approval of DEA Schedule I Registration
May 29 2019 10:00 JST
Lubrizol to Present at the 29th CIMAC World Congress 2019
May 29 2019 10:00 JST
Lubrizol Aims at Circular Economy with TPU Solutions for Footwear
May 17 2019 08:00 JST
Lubrizol Announces Collaboration with Ultimaker's Material Alliance Program
May 15 2019 09:00 JST
Ground Breaking Ceremony at New Lubrizol LUCANT Plant
April 30 2019 08:00 JST
Lubrizol's Diamond Dispersions Business Wins Queen's Award for International Trade
April 23 2019 23:00 JST
Lubrizol to Feature New Bio TPU Grades for 3D Printing and Molded Parts at Plastteknik Fair 2019
April 18 2019 07:30 JST
Lubrizol is Ready for ILSAC GF-6 - Announcing Lubrizol(R) PV1510 Additive Technology for the GF-6 Specification
April 16 2019 07:00 JST
Lubrizol Showcases Renewable-Sourced Estane(R) 3D ECO TPU for 3D Printing at RAPID + TCT 2019
April 12 2019 20:30 JST
More Press release >>
Latest Press Release
New roads await the Toyota Yaris WRC in Croatia
Apr 16, 2021 18:09 JST
Showa Denko Announces Share Transfer with Change in Subsidiary
Apr 16, 2021 16:30 JST
Fujitsu Updates Group Environmental Plan to Achieve Validation of 1.5 degrees Celcius - Aligned Emissions Reduction Targets, Contribute to Sustainable Future
Apr 16, 2021 10:17 JST
Local Production of Hitachi Automatic Analyzer 3500 to Commence in China
Apr 15, 2021 16:42 JST
NextDecade and Mitsubishi Heavy Industries America Execute Engineering Services Agreement for Carbon Capture at Rio Grande LNG Project in Texas
Apr 15, 2021 13:56 JST
Fujitsu Fuels Big Data Innovation in Mobility Space with Launch of "Digital Twin Collector" Platform
Apr 15, 2021 10:44 JST
Mitsubishi Power Receives Order for Two Gas Turbines for 1,500MW Class GTCC Power Plant in Uzbekistan
Apr 14, 2021 15:36 JST
Honda to Introduce First Energy Service for Europe - e:PROGRESS - in the UK
Apr 14, 2021 15:11 JST
Eisai to Present Latest Data on Neurology Products and Pipelines at the American Academy of Neurology Annual Meeting
Apr 14, 2021 13:49 JST
Mazda3 Named Canadian Car of the Year 2021
Apr 14, 2021 12:47 JST
Tokyo Century and DOCOMO to Globally Expand EDGEMATRIX Edge-AI Platform for Video Surveillance & Monitoring
Apr 13, 2021 17:57 JST
Fujitsu Renews Key Systems for Japan Meteorological Agency, Contributing to Completion of Centralized Virtualization Platform
Apr 13, 2021 15:28 JST
NEC recognized as a Partner of the Year by Juniper Networks for two consecutive years
Apr 13, 2021 11:52 JST
Eisai: Animation Featuring Lymphatic Filariasis Elimination Activities Receives Animation Award at International Society for Neglected Tropical Diseases Festival 2021
Apr 12, 2021 13:16 JST
Fujitsu Embarks on Partnership with Siemens Digital Industries Software Strengthening Global Competitiveness and Accelerating DX to Realize Smart, Sustainable Manufacturing
Apr 12, 2021 11:48 JST
Lexus to Display LF-Z Electrified Concept and New ES
Apr 12, 2021 11:09 JST
MHI Invests in Starfire Energy, a Modular Green Ammonia Solution Provider, to Accelerate Efforts to Energy Transition
Apr 09, 2021 17:22 JST
DENSO Develops Advanced Driver Assistance Products for New Lexus LS, Toyota Mirai
Apr 09, 2021 13:46 JST
Deltacore Capital launches Deltacore Digital Global LP
Apr 09, 2021 13:30 JST
Hitachi Astemo to showcase advanced mobility solutions at Auto Shanghai 2021
Apr 09, 2021 13:05 JST
More Latest Release >>